Galecto, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 75 STATE STREET, BOSTON, MA, 02109
Mailing Address 75 STATE STREET, BOSTON, MA, 02109
Phone 45-70-70-52-10
Fiscal Year End 1231
EIN 371957007
Financial Overview
FY2024
-$21.44M
Net Income
$38.23M
Total Assets
$5.90M
Total Liabilities
$61.75M
Stockholders' Equity
$-18.53
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 424B5 Prospectus supplement | February 11, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 10, 2026 | View on SEC |
| 424B5 Prospectus supplement | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
| 3 Initial insider ownership report | January 26, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 12, 2026 | View on SEC |
Insider Trading
SELL 3 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.